Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder

BACKGROUND AND OBJECTIVE: In treating opioid use disorder (OUD), subcutaneous (SC) extended-release buprenorphine (BPN) depots, e.g., CAM2038, have been shown to provide smaller and less frequent fluctuations in BPN plasma concentrations and pharmacodynamic responses, improve outcomes, reduce treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Björnsson, Marcus, Acharya, Chayan, Strandgården, Kerstin, Tiberg, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520114/
https://www.ncbi.nlm.nih.gov/pubmed/37584841
http://dx.doi.org/10.1007/s40262-023-01288-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520114/
https://www.ncbi.nlm.nih.gov/pubmed/37584841
http://dx.doi.org/10.1007/s40262-023-01288-6

Ejemplares similares